Chief Executive Officer
SCYNEXIS, Inc.
Disclosure(s): SCYNEXIS, Inc.: Board Member, SCYNEXIS, INC Officer and Board Member, SCYNEXIS Patents, Stocks/Bonds (Public Company)
Dr. David Angulo, President and Chief Executive Officer of SCYNEXIS, Inc. An infectious disease specialist with more than 20 years of experience in drug development. SCYNEXIS is a biotechnology company, headquartered in Jersey City, New Jersey, committed to positively impacting the lives of patients suffering from difficult-to-treat and often life-threatening infections by delivering innovative anti-infective therapies.